Luke Sergott
Stock Analyst at Barclays
(2.20)
# 2,843
Out of 5,006 analysts
325
Total ratings
42.04%
Success rate
-4.36%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Equal-Weight | $125 → $150 | $141.61 | +5.92% | 12 | Oct 2, 2025 | |
| AVTR Avantor | Maintains: Overweight | $13 → $15 | $14.09 | +6.46% | 26 | Oct 2, 2025 | |
| BRKR Bruker | Maintains: Overweight | $43 → $40 | $36.46 | +9.71% | 6 | Oct 2, 2025 | |
| CERT Certara | Maintains: Overweight | $14 → $16 | $13.45 | +18.96% | 18 | Oct 2, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $55 → $65 | $57.63 | +12.79% | 7 | Oct 2, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Equal-Weight | $180 → $190 | $190.43 | -0.23% | 21 | Oct 2, 2025 | |
| ILMN Illumina | Maintains: Underweight | $90 → $95 | $101.02 | -5.96% | 20 | Oct 2, 2025 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,325 → $1,350 | $1,345.27 | +0.35% | 2 | Oct 2, 2025 | |
| RVTY Revvity | Maintains: Overweight | $110 → $100 | $93.38 | +7.09% | 10 | Oct 2, 2025 | |
| SHC Sotera Health Company | Maintains: Overweight | $17 → $19 | $16.22 | +17.14% | 22 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $550 → $585 | $543.95 | +7.55% | 28 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $40 | $31.85 | +25.59% | 18 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $260 → $275 | $268.07 | +2.59% | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $450 → $425 | $530.30 | -19.86% | 3 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $165 → $195 | $174.95 | +11.46% | 9 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $210 | $170.38 | +23.25% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $15 | $12.64 | +18.67% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $6 | $9.59 | -37.43% | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $87.23 | +3.18% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $185 | $205.02 | -9.76% | 23 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.52 | -1.32% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $225 | $211.71 | +6.28% | 40 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $150.10 | -0.07% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $46.96 | +17.12% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $63.38 | -5.33% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $327.62 | +6.83% | 18 | Apr 10, 2025 |
Agilent Technologies
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $125 → $150
Current: $141.61
Upside: +5.92%
Avantor
Oct 2, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $14.09
Upside: +6.46%
Bruker
Oct 2, 2025
Maintains: Overweight
Price Target: $43 → $40
Current: $36.46
Upside: +9.71%
Certara
Oct 2, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $13.45
Upside: +18.96%
Exact Sciences
Oct 2, 2025
Maintains: Overweight
Price Target: $55 → $65
Current: $57.63
Upside: +12.79%
ICON Public Limited Company
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $180 → $190
Current: $190.43
Upside: -0.23%
Illumina
Oct 2, 2025
Maintains: Underweight
Price Target: $90 → $95
Current: $101.02
Upside: -5.96%
Mettler-Toledo International
Oct 2, 2025
Maintains: Overweight
Price Target: $1,325 → $1,350
Current: $1,345.27
Upside: +0.35%
Revvity
Oct 2, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $93.38
Upside: +7.09%
Sotera Health Company
Oct 2, 2025
Maintains: Overweight
Price Target: $17 → $19
Current: $16.22
Upside: +17.14%
Oct 2, 2025
Maintains: Overweight
Price Target: $550 → $585
Current: $543.95
Upside: +7.55%
Oct 2, 2025
Maintains: Overweight
Price Target: $45 → $40
Current: $31.85
Upside: +25.59%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $260 → $275
Current: $268.07
Upside: +2.59%
Oct 2, 2025
Downgrades: Underweight
Price Target: $450 → $425
Current: $530.30
Upside: -19.86%
Oct 2, 2025
Upgrades: Overweight
Price Target: $165 → $195
Current: $174.95
Upside: +11.46%
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $170.38
Upside: +23.25%
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $12.64
Upside: +18.67%
Aug 7, 2025
Maintains: Underweight
Price Target: $5 → $6
Current: $9.59
Upside: -37.43%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $87.23
Upside: +3.18%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $165 → $185
Current: $205.02
Upside: -9.76%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.52
Upside: -1.32%
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $211.71
Upside: +6.28%
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $150.10
Upside: -0.07%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $46.96
Upside: +17.12%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $63.38
Upside: -5.33%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $327.62
Upside: +6.83%